cerament
-
Biologics
BONESUPPORT announces CERAMENT in combination with bisphosphonate shows promising results in preclinical longterm study
Lund, Sweden, 15.00 CET, 14 April 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries,…
Read More » -
Biologics
CERAMENT® – Now available exclusively through BONESUPPORT
Boston, US, 09.30 ET, 21 May 2019 – BONESUPPORT™ , an emerging leader in orthobiologics for the management of bone voids, is now…
Read More » -
Biologics
BoneSupport TM extends U.S. Distribution agreement for Cerament TM Bone Void Filler
Lund, Sweden, 14 March, 2017 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids…
Read More » -
Financial
BONESUPPORT™ Raises $37 Million (SEK 327 million) to Drive Product Sales and Deliver Further Value From CERAMENT™ Injectable Drug Eluting Bioceramic Platform
LUND, Sweden, October 26, 2016 /PRNewswire/ — BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone scaffolds to treat bone voids…
Read More » -
Biologics
BONESUPPORT™‘s CERAMENT™|G Highly Effective Adjunct in the Single Stage Surgical Management of Chronic Osteomyelitis – Results from Prospective Study of 100 patients Published in The Bone and Joint Journal
Lund, Sweden, 1 September 2016 – BONESUPPORT AB, an emerging leader in innovative injectable bioresorbable bone graft substitute products to…
Read More » -
Hospitals
BONESUPPORT™‘s CERAMENT™|G and CERAMENT™ V to be Featured Extensively at the 35th Annual Meeting of the European Bone & Joint Infection Society (EBJIS) in Oxford, UK
Lund, Sweden, 30 August 2016 – BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat…
Read More » -
Top Stories
BONESUPPORT™ Announces Nature Publication Of Pre-Clinical Study Highlighting CERAMENT™’s Attractive Bone Remodeling Properties and as a Local Drug Delivery Platform for Bone Disease
Lund, Sweden, 1 June 2016 – BONESUPPORT AB, an emerging leader in innovative injectable bioresorbable bone graft substitute products to…
Read More » -
Biologics
BONESUPPORT™ Announces Results Of CERAMENT™|BONE VOID FILLER Prospective Pilot Study Demonstrating Complete Bone Remodeling In Benign Bone Tumors
LUND, Sweden, Dec. 10, 2015 /PRNewswire/ — BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument…
Read More » -
Recon
New Data From Oxford University Hospitals Demonstrate Superior Outcome With CERAMENT™ Antibiotic Eluting Bone Substitute Compared To Collagen And Calcium Sulfate In The Management Of Chronic Osteomyelitis
LUND, Sweden, Oct. 6, 2015 /PRNewswire/ — BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument…
Read More » -
Extremities
CERAMENT™|G Shown To Increase Bone Formation And Decrease Infection
LUND, Sweden, May 27, 2015 /PRNewswire/ — BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation…
Read More » -
Biologics
CERAMENT(TM)|G Featured In Documentary ‘The Orthopaedic Revolution: Treating Osteomyelitis’
LUND, Sweden, Aug. 5, 2014 /PRNewswire/ — BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections…
Read More »